Treat with lansoprazole 30 mg bid for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms (DrugBank: Lansoprazole)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
98 | 好酸球性消化管疾患 | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01404832 (ClinicalTrials.gov) | October 2007 | 27/7/2011 | The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors | The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors | Gastroesophageal Reflux Disease;Eosinophilic Esophagitis | Drug: Treat with lansoprazole 30 mg BID for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms | Dallas VA Medical Center | TAP Pharmaceutical Products Inc. | Terminated | 18 Years | N/A | All | 102 | Phase 4 | United States |